Humana Inc. (HUM) Return on Assets (ROA): 2.04%
Is Humana Inc.’s return on assets (ROA) high or low?
Humana Inc.'s return on assets (ROA) of 2.04% is 63% below its 5-year average of 5.49%, near the low end of its 5-year range (2.44%–9.60%).
The return on assets (ROA) for Humana Inc. (HUM) is 2.04% as of Wednesday, June 10, 2026. It is below its 12-month average by 19.21% (2.52%).
HUM Return on Assets (ROA) Chart
HUM Average Return on Assets (ROA) Chart
HUM Current vs Average Return on Assets (ROA) Chart
HUM Return on Assets (ROA) Metrics
RETURN ON ASSETS (ROA)
2.04%
RETURN ON ASSETS (ROA) AVG TTM
2.52%
RETURN ON ASSETS (ROA) AVG 3Y
4.20%
RETURN ON ASSETS (ROA) AVG 5Y
5.49%
RETURN ON ASSETS (ROA) AVG 10Y
5.96%
RETURN ON ASSETS (ROA) AVG 15Y
6.09%
RETURN ON ASSETS (ROA) AVG 20Y
5.97%
CURRENT VS TTM AVG
-19.21%
CURRENT VS 3Y AVG
-51.37%
CURRENT VS 5Y AVG
-62.83%
CURRENT VS 10Y AVG
-65.75%
CURRENT VS 15Y AVG
-66.49%
CURRENT VS 20Y AVG
-65.86%
HUM Competitors' Return on Assets (ROA)
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Humana Inc. (HUM) | — | 2.04% | 2.52% | 4.20% | 5.49% |
| IDEXX Laboratories, Inc. (IDXX) | $44.47B | 32.35% | 29.29% | 27.30% | 27.52% |
| Agilent Technologies, Inc. (A) | $37.17B | 10.82% | 10.56% | 11.14% | 10.55% |
| Zoetis Inc. (ZTS) | $34.20B | 17.44% | 17.37% | 16.33% | 15.33% |
| Centene Corporation (CNC) | $31.94B | -7.94% | -2.29% | 0.04% | 0.75% |
| IQVIA Holdings Inc. (IQV) | $30.60B | 4.67% | 4.82% | 4.76% | 4.01% |
| DexCom, Inc. (DXCM) | $29.24B | 14.03% | 11.04% | 9.26% | 8.83% |
| Biogen Inc. (BIIB) | $29.00B | 4.65% | 5.11% | 6.74% | 8.29% |
| Veeva Systems Inc. (VEEV) | $26.73B | 10.31% | 9.93% | 9.72% | 10.43% |
| Regeneron Pharmaceuticals, Inc. (REGN) | $62.59B | 10.82% | 11.40% | 12.40% | 16.97% |
Asset Efficiency
ROA
2.0%
ROE
6.1%
Humana Inc. Return on Assets (ROA) Formula & Definition
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Humana Inc. Return on Assets (ROA) FAQ
- What is the return on assets (ROA) for Humana Inc. (HUM)?
- The return on assets (ROA) for HUM stock is 2.04%.
- Is Humana Inc.'s return on assets (ROA) high or low?
- Humana Inc.'s return on assets (ROA) of 2.04% is 63% below its 5-year average of 5.49%, near the low end of its 5-year range (2.44%–9.60%).
- What is the TTM average return on assets (ROA) for Humana Inc. (HUM)?
- The TTM average return on assets (ROA) for HUM stock is 2.52%.
- What is the 3Y average return on assets (ROA) for Humana Inc. (HUM)?
- The 3Y average return on assets (ROA) for HUM stock is 4.20%.
- What is the 5Y average return on assets (ROA) for Humana Inc. (HUM)?
- The 5Y average return on assets (ROA) for HUM stock is 5.49%.
- What is the 10Y average return on assets (ROA) for Humana Inc. (HUM)?
- The 10Y average return on assets (ROA) for HUM stock is 5.96%.
- What is the 15Y average return on assets (ROA) for Humana Inc. (HUM)?
- The 15Y average return on assets (ROA) for HUM stock is 6.09%.
- What is the 20Y average return on assets (ROA) for Humana Inc. (HUM)?
- The 20Y average return on assets (ROA) for HUM stock is 5.97%.
Humana Inc. Return on Assets (ROA) History
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 2.44% |
| 2024-12-31 | 2.61% |
| 2023-12-31 | 5.31% |
| 2022-12-31 | 6.42% |
| 2021-12-31 | 6.55% |
| 2020-12-31 | 9.60% |
| 2019-12-31 | 9.32% |
| 2018-12-31 | 6.64% |
| 2017-12-31 | 9.17% |
| 2016-12-31 | 2.38% |
| 2015-12-31 | 5.08% |
| 2014-12-31 | 4.89% |
| 2013-12-31 | 5.93% |
| 2012-12-31 | 6.26% |
| 2011-12-31 | 7.95% |
| 2010-12-31 | 6.84% |
| 2009-12-31 | 7.35% |
| 2008-12-31 | 4.96% |
| 2007-12-31 | 6.47% |
| 2006-12-31 | 4.81% |
| 2005-12-31 | 4.49% |
| 2004-12-31 | 4.95% |
| 2003-12-31 | 4.23% |
| 2002-12-31 | 3.10% |
| 2001-12-31 | 2.66% |
| 2000-12-31 | 2.16% |
| 1999-12-31 | -7.80% |
| 1998-12-31 | 2.35% |
| 1997-12-31 | 3.19% |
| 1996-12-31 | 0.38% |
Related Metrics
About Humana Inc.
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- James A. Rechtin